SCHEMBL8008606

SCHEMBL8008606

CCc1ccccc1NC=C1C(=O)N(c2ccc(NS(C)(=O)=O)cc2)N=C1C(CC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
GLA P06280 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KAT8 Q9H7Z6 3/20 0.34
DDX3X O00571 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 1/20 0.32
NR3C2 P08235 1/20 0.32
MAPT P10636 2/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
PLA2G7 Q13093 1/20 0.32
LMNA P02545 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8009134 0.91 PLA2G7 (0.34) KDM4EHTTNPSR1PTGS1ALDH1A1
SCHEMBL8011512 0.88 MEN1 (0.39) KDM4EHTTNPSR1KAT8ALDH1A1
SCHEMBL8008615 0.86 KMT2A (0.35) HTTKAT8ALDH1A1HPGDMAPT
SCHEMBL8009329 0.85 SHMT2 (0.37) HTTALDH1A1HPGDMAPTKMT2A
SCHEMBL8008968 0.84 HPGD (0.39) KDM4ENPSR1KAT8ALDH1A1HPGD
SCHEMBL7999795 0.84 TP53 (0.38) HTTKAT8DDX3XALDH1A1MEN1
SCHEMBL8009344 0.84 MAPT (0.43) KDM4EHTTNPSR1KAT8ALDH1A1
SCHEMBL6953049 0.83 ALDH1A1 (0.39) KDM4EGLAHTTNPSR1KAT8
SCHEMBL6953052 0.83 ALDH1A1 (0.39) KDM4EGLAHTTNPSR1KAT8
SCHEMBL8008599 0.80 KMT2A (0.34) KDM4EKAT8DDX3XPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed